Please assess the completion status of the following clinical trial:

Trial Title: Drug Reduction in Older Patients: The DROP Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Referred to SNF (per Physical Therapy and/or Social Work notes)~* Being discharged from the Nashville VA hospital from a medicine or orthopedics team~* Age \> or = 50~* Have polypharmacy, as defined by \> 5 medications based on pre-hospital and in-hospital medications~* Able to self-consent or has a surrogate~Exclusion Criteria:~* Resides in long-term care~* On hospice~* Not expected to discharge within 48 hours of referral

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control--usual care (Type: NO_INTERVENTION): Medication History: All participants / surrogates will receive a structured interview and chart review by the study Pharmacist or Nurse Practitioner at enrollment to determine:~Medications: Medications will include ANY medication with the potential for continuation at the time of hospital discharge to include pre-hospital medications, \[OTC medications\] and active in-hospital medications. Pre-hospital \[and OTC\] medications will be confirmed by Veteran/surrogate interview and pharmacy refills. If a Veteran is admitted from SNF (short-term stay), the investigators will request a copy of the Medication Administration Record (MAR) for the past 30 days. Current medications will be defined as those taken within 30 days prior to the index (enrollment) hospitalization event.
- Intervention--deprescribing protocol (Type: EXPERIMENTAL): In addition to a medication history, a study Pharmacist or Nurse Practitioner will review the reconciled total enrollment medication list. The following information will be ascertained for each medication: (1) Medication Indication; and, (2) Deprescribing rationale: Rationales for deprescribing (i.e., stopping or reducing dose) will be assessed for each medication.~Deprescribing Recommendations: For each medication recommended for deprescribing, the deprescribing action will be specified as: (1) Stop prior to hospital discharge without need for monitoring; (2) Stop prior to hospital discharge with symptoms/physiologic monitoring; (3) Stop at specified time point following hospital discharge; (4) Reduce over time with monitoring until medication is stopped; (5) Reduce to lower dose without need for monitoring; (6) Reduce to lower dose with symptoms/physiologic monitoring.

Based on this trial design, predict the completion outcome and termination type (if applicable).